Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a fixed-dose combination product containing lansoprazole, amoxicillin, and clarithromycin, used for the eradication of *Helicobacter pylori* (*H. pylori*). Lansoprazole is a proton pump inhibitor (PPI), while amoxicillin and clarithromycin are antibiotics.
## Primary Indications
Eradication of *Helicobacter pylori* in patients with peptic ulcer disease.
## Adult Dosing
The typical adult dose is one Somanil HP capsule (containing lansoprazole 30 mg, amoxicillin 1000 mg, and clarithromycin 500 mg) twice daily for 10 to 14 days. It is usually administered in two divided doses, with one dose taken in the morning and one in the evening.
## Pediatric Dosing
Dosing for Sompraz HP in pediatric patients is not established. Separate formulations of lansoprazole, amoxicillin, and clarithromycin may be used at the discretion of the prescriber based on available pediatric guidelines.
## Dose Adjustments
No dose adjustments are generally required for renal or hepatic impairment, as the duration of therapy is limited. However, caution may be warranted in severe renal impairment, and the prescriber should consider individual patient factors.
## Contraindications
* Known hypersensitivity to lansoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of severe hypersensitivity reactions to penicillins, cephalosporins, or other beta-lactam antibiotics.
* History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use.
* Use in patients with a history of QT prolongation, cardiac arrhythmias, significant bradycardia, or electrolyte imbalance (e.g., hypokalemia, hypomagnesemia).
* Concomitant use with cisapride, pimozide, ranolazine, ergotamine, or dihydroergotamine.
## Adverse Effects
Common adverse effects include diarrhea, headache, nausea, abdominal pain, taste perversion, and rash. Less common but serious adverse effects can include severe allergic reactions, Clostridioides difficile-associated diarrhea (CDAD), QT prolongation, tendon rupture (fluoroquinolones, not directly relevant but class effect for macrolides), and hepatotoxicity.
## Key Drug Interactions
* **Lansoprazole:** May decrease the absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, itraconazole, certain HIV protease inhibitors). May affect metabolism of drugs metabolized by CYP2C19 and CYP3A4.
* **Clarithromycin:** Is a potent inhibitor of CYP3A4. Concomitant use with CYP3A4 substrates (e.g., statins, calcium channel blockers, warfarin, theophylline, carbamazepine, cyclosporine, tacrolimus, sirolimus, certain benzodiazepines) can lead to increased plasma concentrations and potential toxicity. Avoid concomitant use with colchicine.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of hypersensitivity reactions.
* Assess for signs and symptoms of CDAD (e.g., watery diarrhea, abdominal cramping, fever).
* Monitor for evidence of *H. pylori* eradication post-treatment (e.g., urea breath test, stool antigen test).
* In patients with known cardiac risk factors or those on medications that prolong the QT interval, consider ECG monitoring.
## Clinical Pearls
* Sompraz HP is a regimen to ensure adherence and simplify treatment.
* Ensure patients complete the full course of therapy, even if symptoms improve.
* Advise patients to take the medication as prescribed, usually with food or milk to minimize gastric irritation.
* If a patient has a penicillin allergy, alternative *H. pylori* eradication regimens should be considered.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and professional resources for complete and accurate drug information, including indications, contraindications, warnings, precautions, adverse reactions, and drug interactions. Local guidelines and institutional protocols may also influence prescribing decisions.
